Skip Ribbon Commands
Skip to main content
A- A A+

Find a Doctor

Dr Susan Hue Swee Shan

  • Consultant, Department of Pathology, National University Hospital
  • Consultant, National University Cancer Institute, Singapore
MBBS (Singapore), PhD (U.K.), FRCPA (Australia)
Special Interests:
Haematopathology, Soft Tissue Pathology, Flow Cytometry


Dr. Susan SS Hue obtained her medical degree from the National University of Singapore (NUS) and her Ph.D from Imperial College London, U.K. in 2009.  She underwent her specialty training in anatomical pathology and became a Fellow of The Royal College of Pathologists of Australasia (FRCPA) in 2015. Other than histopathology reporting, Dr. Hue also holds appointments in Department of Laboratory Medicine for flow cytometry reporting. 

Journals & Publications

  1. ​Hue, S. S.-S. et al. (2023). Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas. Cancers. (2023 IF: 6.6)
  2. Hoppe, M. M., Hue, S.S.S et al. (2023). Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer Discov. (2023 IF 28.2)
  3. Wah, N. W., Hue, S.S.S et al. (2023). Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus–Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma. Mod. Pathol. (2023 IF 8.2)
  4. Hue, S.-S. S., Ng, S.-B., Wang, S., Tan, S.-Y. (2022). Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. Cancers. (2023 IF: 6.6)
  5. Dashraath, P., Hue, S.S.S et al. (2022). Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm. The Lancet. (2023 IF: 202.731)
  6. Tan, H. M., … Hue, S.S.S. (2022). MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics. Int. J. Mol. Sci. (2023 IF 6.2)
  7. Hue, S. S.-S., Oon, M. L., Wang, S., Tan, S.-Y., Ng, S.-B. (2021). Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology (Phila.). (2023 IF: 4.5)
  8. Hue, S. et al. (2020). Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression. Pathology (Phila.). (2023 IF: 4.5)
  9. Mzoughi, S., Hue, S.S.S et al. (2020). PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis. Nat. Commun. (2023 IF: 17.69)
  10. de Mel, S., Hue, S.S.S et al. (2019). Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J. Hematol. Oncol. (2023 IF 23.17)

Professional Memberships

  • ​Fellowship of Royal College of Pathologists of Australasia


Back to Top